SignatureFD’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-466
Closed -$4.15K – 3676
2026
Q2
$4.15K Buy
+466
New +$4.14K ﹤0.01% 2922
2024
Q4
– Sell
-314
Closed -$1.54K – 3420
2024
Q3
$1.54K Buy
+314
New +$2.42K ﹤0.01% 2899

Other funds holding KYTX

SignatureFD's KYTX Position: Q3 2026 in Review

SignatureFD sold out of Kyverna Therapeutics (KYTX) in Q3 2026, closing a stake of 466 shares — an estimated $4.15K sold.

SignatureFD first reported a position in KYTX in Q3 2024 and held it in 2 quarters. The position peaked at $4.15K in Q2 2026. 128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

  • SignatureFD reported no remaining Kyverna Therapeutics position as of Q3 2026 after selling out during the quarter.
  • SignatureFD sold 466 Kyverna Therapeutics shares in Q3 2026, an estimated $4.15K.
  • SignatureFD first reported a position in Kyverna Therapeutics in Q3 2024 and held it in 2 quarters.
  • SignatureFD's Kyverna Therapeutics position peaked at $4.15K in Q2 2026.
  • 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.